Industrial insect farming

food-alt-protein High 7 min
verified 6 Jul 2026 valid until confidence HIGH 25 sources
EC: EU lifting of 'mad cow'-era processed animal protein restrictions on insect meal efsa fda

01Overview and value chain

Markers: [EC: EU lifting of ‘mad cow’-era processed animal protein restrictions on insect meal | OECD: Food systems | Regulator: EFSA (EU), FDA (USA)]

Industrial insect farming scales black soldier fly (Hermetia illucens) and mealworm (Tenebrio molitor) bioconversion into protein meal, lipids and frass fertilizer for feed and pet-food markets. The sector built one of the largest capital bets in the alternative-protein space over the past decade and is now working through a hard correction: Ynsect, which raised over €500 million and built one of the world’s largest insect plants under its FARMYNG project, was reported in January 2026 to have collapsed into insolvency after over-scaling ahead of demand. In North America, Aspire Food Group’s cricket-protein plant in London, Ontario — billed as the world’s largest cricket farm and backed by tens of millions of dollars in government funding — was placed into receivership reportedly owing C$41.5 million. Not every player is retrenching: InnovaFeed raised a fresh €51 million in 2026 to move to commercial scale while trimming R&D spend, Protix redirected its international expansion from a stalled US joint venture with Tyson Foods toward Asia, and India’s Loopworm reports cutting biologics-grade production costs by up to 80% versus conventional methods while targeting ten-fold growth into salmon and tuna feed markets.

Key directions of industrial insect farming:

  1. Black soldier fly bioconversion (Black Soldier Fly Bioconversion): Hermetia illucens larvae processing food waste or agri-residues into protein meal, lipids rich in lauric acid, and frass fertilizer.
  2. Mealworm protein platforms (Mealworm Protein Platforms): Tenebrio molitor farmed at industrial scale for protein meal and lipid fractions, the segment where the sector’s largest capital losses have concentrated.
  3. Capital-efficient regional entrants (Capital-Efficient Regional Entrants): newer, smaller-capex operators (e.g., in India) targeting specific high-value feed niches (aquafeed) rather than replicating the billion-euro flagship-plant model.
  4. Post-overbuild consolidation (Post-Overbuild Consolidation): surviving players pivoting toward leaner operations, cost trims and geographic reallocation (Europe/Asia) rather than continued flagship-scale capital expansion.

Sectoral value chain

Value chain levels

LevelDescriptionKey inputs/outputs
Substrate Sourcingprocuring food waste or agri-residues as larval feedstockIn: food waste, agri-byproducts. Out: rearing substrate.
Larval Rearinggrowing black soldier fly or mealworm larvae at scaleIn: substrate, larvae. Out: grown larval biomass.
Processing & Separationseparating biomass into protein meal, lipid and frass fractionsIn: larval biomass. Out: meal, lipid, frass.
Feed-Safety Certificationclearing processed animal protein rules for feed inclusionIn: product dossier. Out: regulatory clearance.
Commercial Offtakecontracting with aquafeed, livestock feed or pet-food buyersIn: cleared product. Out: offtake agreement.
Aquafeed/Pet-Food Salefinal ingredient sale into formulated feed or pet foodIn: offtake volume. Out: revenue.

Cross-cutting technologies of the sector:

  • Automated larval-rearing systems (Automated Larval-Rearing Systems): vertically stacked, sensor-monitored rearing infrastructure designed for continuous-flow, high-volume production.
  • Lipid fractionation for lauric acid (Lipid Fractionation for Lauric Acid): separating insect fat into a lauric-acid-rich fraction marketed for piglet gut health and antimicrobial effects.
  • Frass fertilizer valorization (Frass Fertilizer Valorization): converting the larval processing byproduct into a marketable organic fertilizer stream alongside the core protein product.

02US

North America’s flagship industrial insect project has become a cautionary tale about scaling ahead of confirmed demand, even as smaller regional players continue operating.

cricket-plant receivership, government-funding scrutiny, consumer-acceptance (‘yuck factor’) barriers

  • Aspire Food Group: its London, Ontario cricket-protein plant — billed as the world’s largest cricket farm and backed by tens of millions of dollars in Canadian federal funding — was placed into receivership reportedly owing C$41.5 million.
  • Consumer-acceptance barrier: press coverage of the Aspire collapse repeatedly cites a persistent “yuck factor” limiting demand growth for insect-derived ingredients even where regulatory and production hurdles are cleared.
  • Government-funding scrutiny: the scale of public subsidy behind a facility that entered receivership has become a specific point of scrutiny in North American coverage of the sector.

03CN

Public information on a dedicated Chinese industrial insect-farming originator at the scale of the EU/North American flagship projects was not confirmed in this pass; the section stays at the policy level.

feed-protein diversification, no confirmed flagship originator, regional funding activity

  • Feed-protein diversification policy: China’s broader push to diversify animal-feed protein sources creates latent demand for insect meal alongside single-cell protein and other alternatives.
  • No confirmed flagship originator: a Chinese company operating an industrial-scale black soldier fly or mealworm facility comparable to Ynsect, InnovaFeed or Protix was not confirmed via live sources in this pass.
  • Adjacent funding activity: a reported Series B round for a French-origin black soldier fly producer circulated in Chinese financial media, reflecting investor interest in the space without confirming a domestic originator.

04EU

The EU is both the origin of the sector’s largest capital losses and the home of its most active pivot-to-commercial-scale players, operating under a 2026 regulatory regime that has fully opened insect protein to livestock feed.

Ynsect insolvency, InnovaFeed’s funding round and R&D trim, Protix’s Asia pivot

  • Ynsect: the French mealworm-bioconversion pioneer, which raised over €500 million and built the FARMYNG flagship plant, was reported in January 2026 to have collapsed into insolvency after high production costs and over-scaling.
  • InnovaFeed: raised a fresh €51 million in 2026 and completed an industrialization phase at its flagship Nesle site, entering a new commercial-scale-focused phase while trimming R&D spend.
  • Protix: halted a planned US joint-venture facility with Tyson Foods and redirected its international expansion toward Asia, citing better day-one cost competitiveness for aquafeed, livestock and pet-food markets there.

05Leading companies and research institutes

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Ynsect🇫🇷 FranceFARMYNG mealworm plantmealworm bioconversion at flagship industrial scaleUnknown (reported insolvency)
InnovaFeed🇫🇷 FranceBlack soldier fly protein, Nesle siteindustrialization completed; €51M 2026 roundCommercial
Protix🇳🇱 NetherlandsBlack soldier fly protein & lipidsAsia-focused expansion after US JV haltCommercial
Aspire Food Group🇺🇸 USACricket protein (Ontario plant)world’s largest cricket farm; in receivershipUnknown (receivership)
Loopworm🇮🇳 IndiaSilkworm/BSF protein & lipidsup to 80% lower biologics production costGrowth

06Tech stack and innovations

The stack is defined as much by cost/scale engineering as by biology.

  1. Vertically stacked automated rearing (Vertically Stacked Automated Rearing):
    • larval-rearing infrastructure is designed for continuous-flow, high-density production to justify large capital plants.
    • case: Ynsect’s FARMYNG plant was built as one of the world’s largest insect-farming facilities on this model before its reported 2026 collapse.
  2. Lauric-acid lipid fractionation (Lauric-Acid Lipid Fractionation):
    • insect fat is separated into a lauric-acid-rich fraction specifically marketed for piglet gut health.
    • case: Protix continues to supply lipid fractions for pig-feed applications even as it redirects its geographic expansion.
  3. Cost-per-unit biologics engineering (Cost-Per-Unit Biologics Engineering):
    • smaller entrants optimize unit production cost rather than replicating flagship-plant capital intensity.
    • case: Loopworm reports cutting biologics-grade production costs by up to 80% versus conventional methods, underpinning a targeted ten-fold growth plan into aquafeed markets.

07Value chains and production pipelines

Industrial pipeline of a black soldier fly/mealworm facility (EU processed-animal-protein feed rules)

Stage 1: Substrate sourcing

Food waste or agri-byproducts are procured as the larval rearing substrate.

Stage 2: Larval rearing

Black soldier fly or mealworm larvae are grown at scale in vertically stacked, automated rearing systems.

Stage 3: Processing/separation

Harvested larval biomass is separated into protein meal, a lauric-acid-rich lipid fraction, and frass fertilizer.

Stage 4: Feed-safety clearance

The product is cleared under processed-animal-protein feed rules (the EU’s 2026 regime fully opens insect protein to poultry and pig feed).

Stage 5: Commercial offtake

Aquafeed, livestock feed or pet-food buyers contract for volume — the stage where several flagship projects have struggled to convert built capacity into confirmed demand.

Stage 6: Aquafeed/petfood sale

The cleared, contracted product reaches its end market; 2026 has shown this final stage is where scale ambition and confirmed demand have diverged most sharply for the sector’s largest projects.

SupplierPriceCertificatesRiskConfidence
YnsectcustomHighMEDIUM
Aspire Food GroupcustomHighMEDIUM
AI Recommendation

AI note: insect-farming-industrial (EN)

Key directions:

  1. Black soldier fly bioconversion — Hermetia illucens larvae processing food waste/agri-residues into protein meal, lipids and frass fertilizer.
  2. Mealworm protein platforms — Tenebrio molitor at industrial scale, the segment where the sector’s largest capital losses concentrated (Ynsect).
  3. Capital-efficient regional entrants — smaller-capex operators (Loopworm, India) targeting specific niches rather than flagship-plant scale.
  4. Post-overbuild consolidation — surviving players (InnovaFeed, Protix) pivoting to leaner operations and geographic reallocation rather than continued flagship expansion.

Regulatory:

  • EU: 2026 regime fully lifts ‘mad cow’-era restrictions on processed animal protein from insects in poultry/pig feed.
  • US: no insect-specific feed statute distinct from general FDA feed-ingredient review; the sector’s US flagship (Aspire) failure was a demand/capital problem, not a regulatory one.

Companies not in table: EnviroFlight and Shandong-based candidates were investigated but excluded — live search returned only generic BSF academic literature (poultry feed conversion studies) or irrelevant hits, no source directly confirming either company’s own current operations; a “NextProtein” Series B mention surfaced in Chinese financial media but without enough text to confirm details, so it was not used as a table row.

Processing note: this is one of the starkest boom-bust corrections found across the whole catalog so far — Ynsect (>€500M raised) and Aspire Food Group (world’s largest cricket farm, tens of millions in government funding) both went from flagship-project status to insolvency/receivership within the same reporting window, while smaller, lower-capex entrants (Loopworm, InnovaFeed post-trim) describe the opposite trajectory. The entity ynsect carries status: unknown here (not pilot, as in the sibling upcycling-biowaste-valuable-products article, which was written before the January 2026 insolvency report) — flagging this for the brain in case a status reconciliation pass across articles is wanted.

Relevance: the “yuck factor” consumer-acceptance barrier cited repeatedly in coverage of the Aspire collapse is a genuine demand-side risk this catalog should track across all insect/novel-protein articles, not just this one — regulatory and production engineering have outpaced willingness to pay in several of the sector’s largest bets.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.